Hydroxychloroquine
Showing 1 - 25 of 727
Hydroxychloroquine May be Beneficial for Preeclampsia
Not yet recruiting
- Pre-Eclampsia
- Hydroxychloroquine
- (no location specified)
Aug 27, 2023
Inflammatory Cardiomyopathy, Myocarditis Trial in Wuhan (Hydroxychloroquine, Prednisolone)
Recruiting
- Inflammatory Cardiomyopathy
- Myocarditis
- Hydroxychloroquine
- Prednisolone
-
Wuhan, Hubei, ChinaTongji Hospital
Jul 18, 2023
Novel ERG for Detection of Hydroxychloroquine Retinopathy
Not yet recruiting
- Hydroxychloroquine Retinopathy
- Hand-Held Full-Field Skin-Electrode Electroretinography (Device to be evaluated)
- +3 more
- (no location specified)
Sep 6, 2023
Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)
Not yet recruiting
- Hydroxychloroquine
- +2 more
- Hydroxychloroquine Combined With Gemcitabine
- (no location specified)
Dec 3, 2022
Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis
Recruiting
- Nonalcoholic Steatohepatitis
- hydroxychloroquine
-
Taipei, Taiwan
- +1 more
Feb 8, 2023
Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)
Not yet recruiting
- Metastatic Colorectal Cancer
- Hydroxychloroquine
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 24, 2023
Individuals Undergoing Cardiac and General Surgery Trial in Durham (Hydroxychloroquine)
Recruiting
- Individuals Undergoing Cardiac and General Surgery
- Hydroxychloroquine
-
Durham, North CarolinaDuke Health
Dec 1, 2022
Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)
Withdrawn
- Solid Tumor
- Advanced Breast Cancer
- Abemaciclib
- +6 more
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022
Clarifying Misbeliefs About Hydroxychloroquine:
Not yet recruiting
- Lupus
- Decision-making tool
- Questionnaire
-
Madison, WisconsinUniversity of Wisconsin
Jun 19, 2023
Pericarditis Idiopathic Recurrent Trial in Athens (Hydroxychloroquine, Colchicine)
Not yet recruiting
- Pericarditis Idiopathic Recurrent
- Hydroxychloroquine
- Colchicine
-
Athens, Attiki, Greece"Hippokration" General Hospital of Athens
Feb 20, 2023
Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)
Recruiting
- Graves Ophthalmopathy
- Hydroxychloroquine
-
Hsinchu, Taiwan
- +1 more
Dec 1, 2022
Interstitial Lung Disease, Surfactant Dysfunction Trial in Shanghai (Hydroxychloroquine)
Not yet recruiting
- Interstitial Lung Disease
- Surfactant Dysfunction
- Hydroxychloroquine
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
Jan 9, 2023
Breast Cancer, Gynecologic Cancer, Early-stage Breast Cancer Trial in Tucson (Hydroxychloroquine)
Not yet recruiting
- Breast Cancer
- +4 more
- Hydroxychloroquine
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Jan 9, 2023
Arthritis, Arthralgia Trial in Edmonton (Hydroxychloroquine, Placebo)
Recruiting
- Arthritis
- Arthralgia
- Hydroxychloroquine
- Placebo
-
Edmonton, Alberta, CanadaCross Cancer Institute
Jan 17, 2023
LPIN1 Mutations Treated With Low Dose Hydroxychloroquine Sulfate
Not yet recruiting
- Lipin-1 Deficiency
- (no location specified)
Sep 29, 2022
Hepatocellular Cancer Trial in San Antonio (Sorafenib (SOR), Hydroxychloroquine (HCQ))
Recruiting
- Hepatocellular Cancer
- Sorafenib (SOR)
- Hydroxychloroquine (HCQ)
-
San Antonio, TexasUniversity of Texas Health Cancer Center
Sep 16, 2022
COVID-19 Trial in São Paulo (Hydroxychloroquine Sulfate, Azithromycin Tablets)
Suspended
- COVID-19
- Hydroxychloroquine Sulfate
- Azithromycin Tablets
-
São Paulo, BrazilPrevent Senior Private Operadora de Saúde LTDA.
Nov 3, 2022
Diabetes Type 2 With Hyperglycemia Trial in Los Angeles (Hydroxychloroquine, Pioglitazone)
Terminated
- Diabetes Mellitus Type 2 With Hyperglycemia
- Hydroxychloroquine
- Pioglitazone
-
Los Angeles, CaliforniaCharles Drew University of Medicine and Science
Sep 23, 2022
Covid-19 Trial in São Paulo (Hydroxychloroquine Sulfate, Azithromycin Tablets)
Suspended
- Covid-19
- Hydroxychloroquine Sulfate
- Azithromycin Tablets
-
São Paulo, BrazilPrevent Senior Private Operadora de Saúde LTDA.
Nov 3, 2022
Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City
Recruiting
- Metastatic Pancreatic Carcinoma
- +6 more
- Hydroxychloroquine
- Trametinib
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Oct 31, 2022
Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago
Recruiting
- Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
- +2 more
- Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
-
Chicago, IllinoisNorthwestern University
Nov 16, 2022
Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)
Active, not recruiting
- Gastrointestinal Cancer
- Cobimetinib
- +2 more
-
New York, New York
- +1 more
Nov 29, 2022
Inhibition of Autophagy Synergizes Anti-tumor Effect Trial in Guangzhou (100mg bid dose of hydroxychloroquine combined with
Recruiting
- Inhibition of Autophagy Synergizes Anti-tumor Effect
- 100mg bid dose of hydroxychloroquine combined with three predefined dose groups of palbociclib
- RP2D dose of 100mg bid of hydroxychloroquine combined with palbociclib was selected for phase II clinical trial.
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jul 19, 2023
Rheumatic Diseases Trial in San Francisco (New e-prescribing interface)
Active, not recruiting
- Rheumatic Diseases
- New e-prescribing interface
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 29, 2022
Systemic Lupus Erythematosus Trial in United States (Hydroxychloroquine, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Hydroxychloroquine
- Placebo
-
Los Angeles, California
- +9 more
Mar 23, 2023